Literature DB >> 1479386

Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

A M Chancellor1, C P Warlow.   

Abstract

This review examines the commonly held premise that, apart from the Western Pacific forms, motor neuron disease (MND), has a uniform worldwide distribution in space and time; the methodological problems in studies of MND incidence; and directions for future epidemiological research. MND is more common in men at all ages. Age-specific incidence rises steeply into the seventh decade but the incidence in the very elderly is uncertain. A rise in mortality from MND over recent decades has been demonstrated wherever this has been examined and may be real rather than due to improved case ascertainment. Comparison of incidence studies in different places is complicated by non-standardised methods of case ascertainment and diagnosis but there appear to be differences between well studied populations. In developed countries in the northern hemisphere there is a weak positive correlation between standardised, age-specific incidence and distance from the equator. There is now strong evidence for an environmental factor as the cause of the Western Pacific forms of MND. A number of clusters of sporadic MND have been reported from developed countries, but no single agent identified as responsible.

Entities:  

Mesh:

Year:  1992        PMID: 1479386      PMCID: PMC1015320          DOI: 10.1136/jnnp.55.12.1106

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  141 in total

1.  Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the U.S., 1977-1986: evidence for an inherently susceptible population subset.

Authors:  J E Riggs
Journal:  Mech Ageing Dev       Date:  1990-09       Impact factor: 5.432

2.  Clinical and electrodiagnostic features of X-linked recessive bulbospinal neuronopathy.

Authors:  R K Olney; M J Aminoff; Y T So
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

Review 3.  Poliovirus and motor neuron disease.

Authors:  C N Martyn
Journal:  J Neurol       Date:  1990-10       Impact factor: 4.849

4.  Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties.

Authors:  P B Christensen; E Højer-Pedersen; N B Jensen
Journal:  Neurology       Date:  1990-04       Impact factor: 9.910

5.  [The natural history of ALS in a specified population, with comments on risk factors, prognosis and symptomatic treatments].

Authors:  F H Norris; E H Denys; K Sang; E Mukai
Journal:  Rinsho Shinkeigaku       Date:  1989-12

6.  Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community.

Authors:  D G Sienko; J P Davis; J A Taylor; B R Brooks
Journal:  Arch Neurol       Date:  1990-01

7.  2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.

Authors:  M W Duncan; J C Steele; I J Kopin; S P Markey
Journal:  Neurology       Date:  1990-05       Impact factor: 9.910

8.  A syndrome of asymmetric limb weakness with motor conduction block.

Authors:  C Krarup; J D Stewart; A J Sumner; A Pestronk; S A Lipton
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

9.  Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976-1986. A geographical study.

Authors:  J D Mitchell; H N Gibson; A Gatrell
Journal:  Arch Neurol       Date:  1990-08

Review 10.  On the possible role of viruses in the aetiology of motor neurone disease: a review.

Authors:  P G Kennedy
Journal:  J R Soc Med       Date:  1990-12       Impact factor: 18.000

View more
  20 in total

1.  Meta-analytic evaluation of the association between head injury and risk of amyotrophic lateral sclerosis.

Authors:  Yukari Watanabe; Takamitsu Watanabe
Journal:  Eur J Epidemiol       Date:  2017-10-27       Impact factor: 8.082

Review 2.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

Review 3.  Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features.

Authors:  A Radunovíc; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

4.  Amyotrophic lateral sclerosis, rural environment and agricultural work in the Local Health District of Ferrara, Italy, in the years 1964-1998.

Authors:  Vittorio Govoni; Enrico Granieri; Elisa Fallica; Ilaria Casetta
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

5.  The economic burden of amyotrophic lateral sclerosis: a systematic review.

Authors:  K Achtert; L Kerkemeyer
Journal:  Eur J Health Econ       Date:  2021-06-18

Review 6.  Motor neuron disease.

Authors:  P N Leigh; K Ray-Chaudhuri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

7.  The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register.

Authors:  A M Chancellor; J M Slattery; H Fraser; R J Swingler; S M Holloway; C P Warlow
Journal:  J Neurol       Date:  1993-06       Impact factor: 4.849

8.  Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register.

Authors:  A M Chancellor; J M Slattery; H Fraser; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

Review 9.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

10.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.